Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CPB1 | P15086 | 2/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
| ▸ | STS | P08842 | 1/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.42 |
| ▸ | PREP | P48147 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14468657 | 1.00 | ALDH1A1 (0.47) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL4040280 | 1.00 | ALDH1A1 (0.47) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL31058400 | 1.00 | ALDH1A1 (0.47) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL18337377 | 0.93 | CPB1 (0.48) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL32672364 | 0.92 | CPB1 (0.53) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL25907340 | 0.92 | CPB1 (0.53) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL6347376 | 0.90 | CPB1 (0.46) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL18335958 | 0.90 | CPB1 (0.46) | ALDH1A1GAACPB1CTSLCTSB | |
| SCHEMBL18337016 | 0.89 | CPB1 (0.45) | ALDH1A1GAACPB1CTSLTSHR | |
| SCHEMBL18337160 | 0.89 | CPB1 (0.45) | ALDH1A1GAACPB1CTSLTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042788-A1 | STAT6 COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042788-A1 | STAT6 COMPOUNDS | STAT6, IL6ST, NFATC1 | ALDH1A1 1587/4885GAA 3545/4885CPB1 2984/4885 |
| US-20060100431-A1 | Biologically active compounds | SOST, CTSK, CTSS | ALDH1A1 4151/4885GAA 1120/4885CPB1 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.